ASCC3 and cancer: Similar to ASCC1 knockdown, reduced ASCC2–ASCC3 affinity, as elicited by several somatic cancer mutations, may influence ASCC2–ASCC3 co-localization at nuclear foci, leading to increased DNA alkylation damage.